URL: http://antibodyregistry.org/AB_2893947
Proper Citation: (Leinco Technologies Cat# LT300, RRID:AB_2893947)
Target Antigen: CD25
Host Organism: human
Clonality: recombinant monoclonal
Comments:
Applications: B, CyTOF®, FC, IF, IHC, WB
Info: This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Basiliximab. Basiliximab recognizes human CD25. This product is for research use only.
We found {{ ctrl2.mentions.total_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
Check
for all resource mentions.
A list of researchers who have used the resource and an author search tool
Find mentions based on location
{{ ctrl2.mentions.errors.location }}
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-Human IL-2R alpha (CD25) (Basiliximab).
No alerts have been found for Anti-Human IL-2R alpha (CD25) (Basiliximab).
Source: Antibody Registry
